Results 51 to 60 of about 4,426 (152)

Management of venous thromboembolism in patients with cancer: role of dalteparin

Vascular Health and Risk Management, 2008
Lori-Ann LinkinsDepartment of Hematology and Thrombosis, McMaster University, Hamilton, Ontario, CanadaAbstract: Cancer is a major risk factor for the development of venous thromboembolism (VTE).
Lori-Ann Linkins
doaj  

Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study

Thrombosis Journal, 2020
Background Advanced pancreatic ductal adenocarcinoma (aPDAC) patients have a lifetime all type thromboembolic event (ATTE) rate of 25–35%. Efficacy and safety of increased dose primary thromboprophylaxis (IDPTP) with low molecular heparin (LMWH) given ...
Anthony Maraveyas, Farzana Haque, Iqtedar Ahmed Muazzam, Waqas Ilyas, George Bozas   +4 more
doaj   +1 more source

Borna disease virus infection: Retrospective case series of five horses and two donkeys in Switzerland

Equine Veterinary Education, Volume 38, Issue 3, Page e119-e129, March 2026.
Summary Borna disease is an acute to subacute, rarely chronic non‐purulent meningoencephaylomyelitis affecting mainly horses and sheep. This case series describes the clinical signs, diagnosis, treatment, outcome and post‐mortem findings of five horses and two donkeys with this condition. The equids affected were geldings or mares of various breeds and
I. L. Piotrowski, M. Hilbe, H. K. Junge
wiley   +1 more source

Increased Urine IgM and IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

Biochemistry Research International, 2012
Fifty-four type 2 diabetic patients with neuroischemic foot ulcers were randomised to treatment with 5000 IU of dalteparin, (n=28), or physiological saline, (n=26), once daily until ulcer healing or for a maximum of 6 months.
Ole Torffvit, Majid Kalani, Jan Apelqvist, Björn Eliasson, Jan W. Eriksson, Kerstin Brismar, Gun Jörneskog   +6 more
doaj   +1 more source

Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties

Haematologica, 2006
BACKGROUND AND OBJECTIVES: Heparins, including unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH), are glycosaminoglycans that are largely used as anti-thrombotic drugs. While the mechanisms of their anticoagulant actions in blood have
A Vignoli, M Marchetti, D Balducci, T Barbui, A Falanga   +4 more
doaj  

Incidence of Deep Vein Thrombosis in Patients Undergoing Degenerative Spine Surgery on Prophylactic Dalteparin; A Single Center Report [PDF]

Bulletin of Emergency and Trauma, 2016
Objective: To determine the incidence of deep vein thrombosis (DVT) in patients undergoing spinal surgeries receiving prophylactic doses of Deltaparin in a single center in central Iran.Method: This cross-sectional study was conducted in Shariatee ...
Alireza Farid Moayer, Navideh Mohebali, Ali Razmkon   +2 more
doaj   +2 more sources

Dalteparin sodium [PDF]

Reactions Weekly, 2020
  +5 more sources

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin^® added to standard therapy in patients with lung cancer

BMC Cancer, 2009
Background Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus).
Macbeth Fergus R, Noble Simon I, Burns Sarah, Griffiths Gareth O, Cohen David, Maughan Timothy S   +5 more
doaj   +1 more source

Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.

PLoS ONE, 2015
BackgroundT-cell-mediated inflammatory cytokines, such as interleukin (IL)-4, IL-5, IL-13 and tumor necrosis factor-alpha (TNF-α), play an important role in the initiation and progression of inflammatory airways diseases.
Madhur D Shastri, Niall Stewart, Mathew Eapen, Gregory M Peterson, Syed Tabish R Zaidi, Nuri Gueven, Sukhwinder Singh Sohal, Rahul P Patel   +7 more
doaj   +1 more source

Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation

Кардиоваскулярная терапия и профилактика, 2011
Aim. To compare anti-Xa plasma activity levels in patients with acute coronary syndrome (ACS) and no ST segment elevation (non-STE ACS), receiving enoxaparin, nadroparin, or dalteparin. Material and methods.
R. M. Linchak, V. S. Popov, K. F. Kim
doaj